| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 13 Nov 2025 | 7 Nov 2025 |
| Natraj Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve the following businesses along with other routine businesses: 1. Approval of the Un-Audited Financial Results of the Company for the Quarter/ Half year ended 30th September2025. 2. To take on Record the Limited Review Report by the Auditors for the Unaudited Financial Results of the Company for the Quarter/ Half year ended 30th September2025. 3. Approval of the Un-Audited Statement of Assets and Liabilities for the Half year ended 30th September2025; 4. Approval of the Un-Audited Statement of Cash Flow for the Half year ended 30th September2025; and 5. Any other business. Pursuant to Regulation 33 of SEBI(LODR), 2015, we are pleased to submit the Financial Results for the Qaurter and Half Year ended 30th September, 2025. We are pleased to submit the Outcome of the Board Meeting held on 13/11/2025 for approval of the unaudited quarterly/half year financial statements for the quarter/half year ended on 30/09/2025 alongwith other routine matters. (As Per BSE Announcement Dated on 13.11.2025) | ||
| Board Meeting | 13 Aug 2025 | 7 Aug 2025 |
| Natraj Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 inter alia to consider and approve NATRAJ PROTEINS LTD. has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 inter alia to consider and approve Pursuant to Regulation 29(1)(a) of SEBI (LODR) Regulations 2015 read with SEBI (Prohibition of Insider Trading) Regulations 2015 as may be applicable we are pleased to inform that 03/2025-26 Meeting of the Board of directors of the Company is scheduled to be held on 13/08/2025 at 3:00 P.M. at the Registered office of the company situated at Nagpur Kalan Ordinance Factory Road Itarsi (M.P.) 461111 to consider and approve the following businesses along with other routine businesses: 1. To consider and approve the Standalone Un-Audited Financial Results of the Company for the Quarter ended 30th June 2025. 2. To consider and approve the Limited Review Report by the Statutory Auditors for the Standalone Un-Audited Financial Results of the Company for the Quarter ended 30th June 2025. 3. Other Routine Business Items. | ||
| Board Meeting | 21 Jul 2025 | 21 Jul 2025 |
| Intimation pursuant to Reg. 30 read with Clause 7 of Para A of Schedule III of SEBI(LODR) Regulation, 2015 for Appointment of Company Secretary and Compliance officer of the Company. | ||
| Board Meeting | 21 May 2025 | 16 May 2025 |
| Natraj Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2025 inter alia to consider and approve the following businesses along with other routine businesses: 1. To consider & approve the Audited financial results of the Company for the Quarter/Year ended 31st March 2025. 2. To take on record the Audit Report of the Statutory Auditors for the Audited Financial Results of the Company for the Quarter/Year ended 31st March 2025. 3. To consider and approve the Standalone Audited Financial Statements including the Balance Sheet as at 31st March 2025 and the Statement of Profits and Loss and Cash flow Statement of change in equity and notes thereon for the year ended 31st March 2025. 4. Other Routine Business Items Pursuant to Regulation 33(3)(d) of SEBI (LODR) Regulations, 2015, we are pleased to submit the Standalone Audited Financial Results along with Auditors Report thereon by Statutory Auditors, Statement of Assets and Liabilities and Cash Flow for the quarter/year ended on 31st March, 2025, in PDF Format, which were approved by the Audit Committee and Board of Directors at their meeting held on Wednesday, 21st May, 2025. (As Per BSE Announcement Dated on: 21/05/2025) | ||
| Board Meeting | 12 Feb 2025 | 4 Feb 2025 |
| NATRAJ PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve 1. Approval of the Un-Audited Financial Results of the Company for the Quarter and Nine months ended on 31st December 2024. 2. To take on Record the Limited Review Report by the Auditors for the Un-Audited Financial Results of the Company for the Quarter and Nine months ended on 31st December 2024. 3. Other regular matters. | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.